跳至主要内容
临床试验/CTRI/2021/05/033573
CTRI/2021/05/033573已完成未知

Estimation of the levels of macrophage polarization markers - Nitric oxide, CD 163 and MicroRNA 21, in the saliva of healthy, gingivitis and periodontitis patients with and without diabetes mellitus; An analytical case control study

AKSHAYA J0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Based on 2017 World Workshop on the Classification of Periodontal and Peri-implant diseases and conditions, co-presented by the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP),
  • Inclusion criteria for Healthy group:
  • 1.Pristine periodontal health:
  • i. No bleeding on probing.
  • ii. Normal gingival sulcus depth.
  • iii. Normal bone heights.
  • iv. Controlled modifying factors.
  • v. Controlled predisposing factors.
  • 2.Clinical periodontal health (intact periodontium):
  • i. No or minimal bleeding on probing.
  • ii. Normal gingival sulcus depth.
  • iii. Normal bone heights.
  • iv. Controlled modifying factors.
  • v. Controlled predisposing factors.
  • Inclusion criteria for Gingivitis group:
  • i.Absence of CAL
  • ii.PPD < 3mm
  • iii.BOP present
  • Inclusion criteria for Stage III/IV Periodontitis:
  • According to the new classification scheme (Kornman and Tonetti et al, 2018).
  • 1.Stage III:
  • i.Interdental clinical attachment loss at site of greatest loss >= 5mm.
  • ii.Radiographic bone loss extending to middle or apical third of root
  • iii.Tooth loss due to periodontitis <= 4 teeth.
  • iv.Probing depth >= 6mm.
  • v.Extent: Greater than 30% of teeth involved (Generalized)
  • 2.Stage IV:
  • i.Interdental clinical attachment loss at site of greatest loss >= 5mm.
  • ii.Radiographic bone loss extending to middle or apical third of root
  • iii.Tooth loss due to periodontitis >= 5 teeth.
  • iv.Extent: Greater than 30% of teeth involved (Generalized)
  • Inclusion criteria for Type 2 Diabetes mellitus
  • 1.Patients with HbA1c levels more than 8% will be taken for the study in the groups involving Diabetes. (According to American Diabetes Association guidelines 2018)

排除标准

  • 1.Pregnant women
  • 2.Pregnant and lactating women.
  • 3.Habits like tobacco ,smoking
  • 4.Patients with immunodeficiency disorders.
  • 5.Patients with other systemic inflammatory conditions like sepsis, pneumonia, pleural effusion, intra-abdominal infections, inflammatory bowel disorders, inflammatory rheumatoid disorders, chronic kidney disease, cancers, atherosclerosis, COPD, asthma, HIV and hepatitis will be excluded from the study.
  • 6.Patients with systemic diseases like hypertension
  • 7.History of periodontal treatment within the previous 6 months.
  • 8.History of antibiotic therapy in the past 3 months.
  • 9.Subjects who are not willing to participate in the study

研究者

发起方
AKSHAYA J

相似试验